Get coverage of the latest pharmaceutical business developments

As a business and portfolio strategy professional, it’s important that you understand the diseases and market landscape, unmet needs, and the best candidates available for in-licensing, out-licensing or acquisition. To best evaluate your target list, you need to benchmark other relevant transactions in the space, and compare deal structures and mix of financial payments and milestones. You’ll want to:

• Know when a candidate fitting your strategy moves into Phase II and in which diseases
• Understand the current competition, and assess recent in- and out-licensing activity for similar drugs, or disease population

Alerts for these potential opportunities are a must-have.

 How we can help

With our comprehensive coverage of industry meetings and financial conferences, and analyst calls, we arm you with timely and accurate intelligence you can act on, including:

• Coverage of deals, partnerships, acquisitions, and venture financing
• Benchmarking trends for drugs and deals
• Drug pipeline tracking and assessment
• Patent and generic coverage
• Clinical and regulatory events
• Likelihood of product approval and advisory committee insights
• Drug delivery technologies
• Competitive landscape tools and analysis
• Company profiles